Mechanisms and possible hepatoprotective effects of glucagon-like peptide-1 receptor agonists and other incretin receptor agonists in non-alcoholic fatty liver disease.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Mechanisms and possible hepatoprotective effects of glucagon-like peptide-1 receptor agonists and other incretin receptor agonists in non-alcoholic fatty liver disease.
- Published In:
- The lancet. Gastroenterology & hepatology, 8(2), 179-191 (2023)
- Authors:
- Targher, Giovanni(4), Mantovani, Alessandro(3), Byrne, Christopher D(3)
- Database ID:
- RPEP-07450
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-07450APA
Targher, Giovanni; Mantovani, Alessandro; Byrne, Christopher D. (2023). Mechanisms and possible hepatoprotective effects of glucagon-like peptide-1 receptor agonists and other incretin receptor agonists in non-alcoholic fatty liver disease.. The lancet. Gastroenterology & hepatology, 8(2), 179-191. https://doi.org/10.1016/S2468-1253(22)00338-7
MLA
Targher, Giovanni, et al. "Mechanisms and possible hepatoprotective effects of glucagon-like peptide-1 receptor agonists and other incretin receptor agonists in non-alcoholic fatty liver disease.." The lancet. Gastroenterology & hepatology, 2023. https://doi.org/10.1016/S2468-1253(22)00338-7
RethinkPeptides
RethinkPeptides Research Database. "Mechanisms and possible hepatoprotective effects of glucagon..." RPEP-07450. Retrieved from https://rethinkpeptides.com/research/targher-2023-mechanisms-and-possible-hepatoprotective
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.